Hasil Filter

17430

Total database: 17430
Struktur (SMILES)
12313 (70.6%)
Target
9368 (53.7%)
Genomik
112 (0.6%)
Referensi
17430 (100.0%)

Tipe Molekul

Distribusi Wujud Zat

Status Regulasi

Hasil Pencarian (17430)

Halaman 94 / 349
BMS-986020 DB14948
small molecule | CAS: 1257213-50-5

BMS-986020 is under investigation in clinical trial NCT02017730 (To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding in Lung Using PET (Positron Emission Tomography) In Healthy Volunteers).

Target Protein:
Lysophosphatidic acid receptor 1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
BMS-986094 DB11966
small molecule | CAS: 1234490-83-5

INX-08189 has been used in trials studying the treatment of Hepatitis C, HCV (Genotype 1), and Hepatitis C Virus.

Kategori:
Guanine NucleotidesHeterocyclic Compounds, Fused-RingNucleic Acids, Nucleotides, and Nucleosides +4
Target Protein:
Genome polyprotein
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
BMS-986104 DB15214
small molecule | CAS: 1622180-31-7

BMS-986104 is under investigation in clinical trial NCT02211469 (A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986104 in Healthy Male Subjects).

Target Protein:
Sphingosine 1-phosphate receptor 1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
BMS-986115 DB13126
small molecule | CAS: 1584647-27-7

BMS-986115 has been used in trials studying the treatment of Various Advanced Cancer.

Kategori:
BenzazepinesEnzyme InhibitorsGamma Secretase Inhibitors and Modulators +1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
BMS-986141 DB14942
small molecule | CAS: 1478711-48-6

BMS-986141 is under investigation in clinical trial NCT02985632 (A Study to Evaluate the Pharmacokinetics of BMS-986141 in Participants With Hepatic Impairment Compared to Healthy Participants).

Kategori:
Acids, CarbocyclicAmidesBenzene Derivatives +3
Target Protein:
PRKC apoptosis WT1 regulator protein
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
BMS-986142 DB15291
small molecule | CAS: 1643368-58-4

BMS-986142 is under investigation in clinical trial NCT02880670 (Pharmacokinetics and Metabolism Study of Radiolabeled BMS-986142 in Healthy Male Subjects).

Target Protein:
Tyrosine-protein kinase BTK
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
BMS-986158 DB15435
small molecule | CAS: 1800340-40-2

BMS-986158 is under investigation in clinical trial NCT02419417 (Study of BMS-986158 in Subjects With Select Advanced Cancers).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
BMS-986251 DB19007
small molecule | CAS: 2041841-30-7

BMS-986251 is under investigation in clinical trial NCT03329885 (A Study of Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
BMS-986278 DB18011
small molecule | CAS: 2170126-74-4

Deskripsi belum tersedia.

Target Protein:
Lysophosphatidic acid receptor 1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
BMS184394 DB03466
small molecule

Deskripsi belum tersedia.

Target Protein:
Retinoic acid receptor gamma
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
BMSC-0013 DB02474
small molecule

Deskripsi belum tersedia.

Target Protein:
Cholera enterotoxin subunit B
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
small molecule | CAS: 1379866-50-8

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
BN-201 DB18295
small molecule | CAS: 1361200-34-1

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
BN-82451 DB16950
small molecule | CAS: 335242-75-6

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
BN104 DB18172
small molecule

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

BN?Brachyury vaccine is a novel prime?boost therapeutic cancer immunotherapy. It is composed of the [MVA-BN-brachyury-TRICOM vaccine] and the fowlpox virus(FPV)?Brachyury booster vaccine.[A255173]

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
BNC-210 DB19048
small molecule | CAS: 1020634-41-6

BNC-210 is under investigation in clinical trial NCT04951076 (A Phase 2b Study of BNC210 Tablet Formulation in Adults With Post-traumatic Stress Disorder (PTSD)).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
BNC105 DB06313
small molecule | CAS: 945772-45-2

Deskripsi belum tersedia.

Kategori:
Benzene DerivativesEthersHeterocyclic Compounds, Fused-Ring +3
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
BNT-162A1 DB16402
biotech | CAS: 2417899-74-0

BNT-162A1 is under investigation in clinical trial NCT04380701 (A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults).

Kategori:
Amino Acids, Peptides, and ProteinsAntigensBiological Factors +10
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
BNT111 DB18177
biotech

BNT111 is an investigational cancer immunotherapy under development for advanced melanoma. It consists of a fixed combination of mRNA-encoded, tumor-associated antigens.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

BNT162a1 is one of four advanced mRNA-based vaccines being developed through "Project Lightspeed," a joint program between Pfizer and BioNTech.[L15002, L15007] BNT162a1 is a uridine mRNA (uRNA) vaccine formulated in lipid nanoparticles for delivery via intram…

Kategori:
Experimental Unapproved Treatments for COVID-19
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

BNT162b1 is one of four advanced mRNA-based vaccines being developed through "Project Lightspeed," a joint program between Pfizer and BioNTech.[L15002, L15007] BNT162b1 is a nucleoside modified mRNA (modRNA) vaccine encoding the receptor-binding domain (RBD) …

Kategori:
Amino Acids, Peptides, and ProteinsAntigensBiological Factors +11
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
BNT162b2 Omicron (KP.2) Approved DB19415
biotech

BNT162b2 Omicron (KP.2) is COVID-19 mRNA vaccine encoding the viral spike (S) glycoprotein of SARS-CoV-2 Omicron variant lineage KP.2. It is the active ingredient in the 2024-2025 formulation of Pfizer-BioNTech's Comirnaty vaccine.[L36030]

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
BNT162b3 DB16442
biotech

The BNT162b3 vaccine is the latest addition to BioNTech and partner Pfizer’s mRNA COVID-19 vaccine program. Similar to [BNT162b2], BNT162b3 uses a nucleoside-modified RNA (modRNA) technology. Pfizer and BioNTech deemed this compound as promising in preclinica…

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

BNT162c2 is one of four advanced mRNA-based vaccines being developed through "Project Lightspeed," a joint program between Pfizer and BioNTech.[L15002, L15007] BNT162c2 is a self-amplifying mRNA (saRNA) vaccine formulated in lipid nanoparticles for delivery v…

Kategori:
Experimental Unapproved Treatments for COVID-19
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
BO-653 DB19216
small molecule | CAS: 157360-23-1

BO-653 is under investigation in clinical trial NCT00055510 (A Blinded Study Conducted at Multiple Centers Evaluating Various Doses of an Investigational Agent (BO-653) Against Placebo, for Safety and Effectiveness in Preventing Post-angioplasty Blood Vessel …

Kategori:
Heterocyclic Compounds, Fused-Ring
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
small molecule

Deskripsi belum tersedia.

Target Protein:
D-alanyl-D-alanine carboxypeptidase DacAD-alanyl-D-alanine carboxypeptidase DacA
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Boceprevir Approved DB08873
small molecule | CAS: 394730-60-0

Boceprevir is a direct acting antiviral medication used as part of combination therapy to treat chronic Hepatitis C, an infectious liver disease caused by infection with Hepatitis C Virus (HCV). HCV is a single-stranded RNA virus that is categorized into nine…

Kategori:
Amino AcidsAmino Acids, CyclicAmino Acids, Peptides, and Proteins +21
Target Protein:
Genome polyproteinGenome polyprotein
Waktu ParuhBoceprevir has a me…
Vol. DistribusiThe mean apparent v…
KlirensBoceprevir has a me…
Genetik -
Bocidelpar DB16906
small molecule | CAS: 2095128-20-2

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
small molecule | CAS: 2356354-82-8

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Bococizumab DB12456
biotech | CAS: 1407495-02-6

Bococizumab has been used in trials studying the treatment and prevention of Dyslipidemia, Hyperlipidemia, Hypercholesterolemia, Cardiovascular Disease, and Heterozygous Familial Hypercholesterolemia.

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +11
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Bolandiol DB01554
small molecule | CAS: 19793-20-5

Deskripsi belum tersedia.

Kategori:
EstranesEstrenesFused-Ring Compounds +6
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Bolasterone DB01471
small molecule | CAS: 1605-89-6

Deskripsi belum tersedia.

Kategori:
Anabolic AgentsAndrostanesAndrostenes +8
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Boldenone DB01541
small molecule | CAS: 846-48-0

Boldenone is an anabolic steroid developed for veterinary use, mostly for treatment of horses. It is not indicated for use in humans in the US and is only available through veterinary clinics.

Kategori:
Anabolic AgentsAndrostanesAndrostenes +9
Target Protein:
Androgen receptor
Waktu Paruh14 days
Vol. Distribusi-
Klirens-
Genetik -
small molecule | CAS: 13103-34-9

Deskripsi belum tersedia.

Kategori:
AndrostanesAndrostenesAndrostenols +6
Target Protein:
Androgen receptor
Waktu Paruh14 days
Vol. Distribusi-
Klirens-
Genetik -
Boldione DB07373
small molecule | CAS: 897-06-3

Deskripsi belum tersedia.

Kategori:
AndrostanesAndrostenesFused-Ring Compounds +1
Target Protein:
AromatasePentaerythritol tetranitrate reductase
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Boldo leaf extract Approved DB15815
biotech

Boldo leaf extract allergenic extract is used in allergenic testing.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Bombesin DB11724
small molecule | CAS: 31362-50-2

Bombesin is under investigation in clinical trial NCT01205321 (PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-7548 in Patients With Prostate Cancer and Healthy Volu…

Kategori:
Amino Acids, Peptides, and ProteinsAmphibian VenomsBiological Factors +12
Target Protein:
Gastrin-releasing peptide receptorBombesin receptor subtype-3Neuromedin-B receptor
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Bombykol DB02982
small molecule

Deskripsi belum tersedia.

Kategori:
AlcoholsLipids
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Bombyx mori fiber Approved DB10609
biotech

Bombyx mori fiber is used in allergenic testing.

Kategori:
Cell-mediated ImmunityIncreased Histamine ReleaseIncreased IgG Production +1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Bomedemstat DB17234
small molecule | CAS: 1990504-34-1

Deskripsi belum tersedia.

Kategori:
Acids, CarbocyclicAmidesBenzene Derivatives +1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech | CAS: 2364477-20-1

Deskripsi belum tersedia.

Kategori:
Adeno-associated Viral Vector Therapies
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Bopindolol DB08807
small molecule | CAS: 62658-63-3

Bopindolol (INN) is an ester prodrug for the beta blocker [pindolol].

Kategori:
Adrenergic AgentsAdrenergic AntagonistsAdrenergic beta-Antagonists +12
Target Protein:
Beta-1 adrenergic receptorBeta-2 adrenergic receptorBeta-3 adrenergic receptor +2
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Borage oil Approved DB11238
biotech

Borage oil, or borage seed oil, is a rich source of gamma-linolenic acid (GLA) that is obtained from the seeds of the Borago officinalis (borage). Borage oil is used as an herbal treatment of skin disorders including eczema, seborrheic dermatitis, and neurode…

Kategori:
Agents that reduce seizure thresholdAntirheumatic AgentsBiological Products +11
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Borate ion DB14553
small molecule | CAS: 12258-53-6

Deskripsi belum tersedia.

Kategori:
AnionsBoric AcidsBoron Compounds +2
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) is a vaccine that contains inactivated acellular pertussis antigen that is isolated from Bordetella pertussis culture.

Kategori:
Actively Acquired ImmunityInactivated Bordetella Pertussis Vaccine
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

Bordetella pertussis fimbriae 2/3 antigen is a vaccine for the prophylaxis of the disease caused by Bordetella pertussis which is a a Gram-negative coccobacillus that expresses two serologically distinct fimbriae (Fim2 and Fim3).

Kategori:
Actively Acquired ImmunityInactivated Bordetella Pertussis Vaccine
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

Bordetella pertussis pertactin antigen is a vaccine for the prophylaxis of whooping cough that contains pertactin, a membrane-associated antigen of Bordetella pertussis [A31248].

Kategori:
Amino Acids, Peptides, and ProteinsBacterial ProteinsBacterial Toxins +7
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

Deskripsi belum tersedia.

Kategori:
Actively Acquired ImmunityInactivated Bordetella Pertussis Vaccine
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

Bordetella pertussis toxoid antigen (formaldehyde inactivated) is a vaccine.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Menampilkan 4651–4700 dari 17430
Sebelumnya Halaman 94 / 349 Berikutnya